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Background: Our previous study demonstrated that the A-allele of the single nucleotide polymorphism (SNP)
rs34623097 located in the upstream region of the β2 adrenergic receptor gene (ADRB2) is significantly associated
with risk for obesity in Oceanic populations.
Methods: To investigate whether the ADRB2 polymorphisms explain part of the individual differences in lipid
mobilization, energy expenditure and glycogen breakdown, the associations of 10 ADRB2 SNPs with total
cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol and triglyceride levels were
examined in 128 adults in Tonga.
Results: A multiple linear regression analysis adjusted for age, sex, and body mass index revealed that rs34623097
was significantly associated with triglyceride levels (P-value = 0.037). A copy of the rs34623097-A allele increased
serum triglyceride levels by 70.1 mg/dL (0.791 mmol/L). None of the ADRB2 SNPs showed a significant association
with total-cholesterol, high-density lipoprotein cholesterol, or low-density lipoprotein cholesterol.
Conclusions: In a Tongan population, a SNP located in the upstream region of ADRB2 is associated with
triglyceride levels independent of body mass index.
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The β2 adrenergic receptor (ADRB2), a class of G
protein-coupled receptor for catecholamines, plays an
important role in regulating energy expenditure and
lipolysis in adipose tissue. Therefore, polymorphisms in
the ADRB2 gene (OMIM*109690) may explain part of
the individual differences in lipid profiles. The 27Glu al-
lele at the Glu27Gln polymorphism of ADRB2 has been
significantly associated with increased triglyceride levels
[1-6], although there is a conflicting report that demon-
strated a significant increase in triglyceride levels in in-
dividuals with the Gln/Glngenotype as compared to
those with the Glu/Glugenotype [7].
Most studies have examined the association of three non
synonymous ADRB2 SNPs, rs1042711 (5’LC-Arg19Cys in
the 5’ upstream region), rs1042713 (Gly16Arg) and
rs1042714 (Glu27Gln), with lipid profiles (i.e., total
cholesterol, high-density lipoprotein [HDL] cholesterol,* Correspondence: juno-tky@umin.ac.jp
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reproduction in any medium, provided the orlow-density lipoprotein [LDL] cholesterol and triglycer-
ide levels). However, ourrecent study showed that
rs34623097 located in the upstream region of ADRB2 is
more strongly associated with obesity than non syn-
onymous SNPs in Oceanic populations. A functional
analysis suggested that rs34623097-A, a risk allele for
obesity, reduces the transcriptional activity of ADRB2 as
compared with rs34623097-G [8]. The aim of the
present study is to further explore the association of
ADRB2 SNPs including rs34623097 with lipid profiles
independent of body mass index (BMI) in adult Tongan
subjects.Results
Subject characteristics
A total of 128 unrelated subjects (40 men and 88 women)
were recruited for the present study. The clinical and la-
boratory parameters of participants are summarized in
Table 1. The median values of total cholesterol and triglyc-
erides in Tongan male subjects exceeded the desirable
ranges of less than 200 mg/dL for total cholesterol andd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Clinical characteristics of subjects
Characteristic Overall Male Female
(n = 128) (n = 40) (n = 88)
Age 44 (33–53) 49 (36–55) 42 (32–51)
Height (cm) 167.4
(162.3-170.1)
172.5
(170.5-177.3)
164.2
(160.5-168.1)
Weight (kg) 96.9
(85.7-108.4)
100.1
(90.0-109.2)
96.3
(84.5-107.2)
BMI (kg/m2) 35.3 (31.2-39.3) 32.4 (29.9-36.5) 35.9 (31.5-40.1)
Total cholesterol
(mg/dL)
199 (173–224) 203 (176–230) 197 (170–218)
HDL cholesterol
(mg/dL)
45 (40–52) 42 (38–49) 47 (42–52)
LDL cholesterol
(mg/dL)
128 (109–147) 125 (114–154) 129 (107–146)
Triglyceride
(mg/dL)
107 (73–155) 152 (104–216) 99 (62–129)
Data are presented as median (interquartile range); BMI Body Mass Index, HDL
High Density Lipoprotein, LDL Low Density Lipoprotein.
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associated with total cholesterol and LDL cholesterol; sex
and BMI were significantly associated with HDL choles-
terol and triglycerides (Table 2).
Association of ADRB2 polymorphisms with lipid profiles
Two samples for rs11959427, three samples for rs1042713,
and two samples for rs1042714 were not successfully geno-
typed by a molecular biology-based technique. To avoid a
reduction in statistical power, these genotypes were im-
puted by using the MACH software [9]. Then we manually
checked the imputed genotypes based on the LD structure
(Figure 1), and concluded that the imputed genotypes
seemed to be valid. The following analyses were therefore
performed for the data including the imputed genotypes.
No significant deviation from Hardy-Weinberg equilibrium
was observed for the 10 ADRB2 SNPs.
We adjusted the crude effect of each ADRB2 SNP by
taking into account age, sex and BMI, since these variables
are significantly associated with lipid traits (Table 2). A
multiple linear regression analysis adjusted for age, sex,Table 2 Association of age, sex and BMI with lipid traits
Independent variable
Total cholesterol (mg/dL) HDL choleste
β SE P-value β SE
Age (years) 1.1 0.33 1.0 x 10-3 0.0031 0.063
Sex (Male = 0, Female = 1) −3.4 8.6 0.70 5.6 1.6
BMI (kg/m2) 0.42 0.65 0.52 −0.47 0.12
A multiple regression analysis was performed to examine the association of age, se
Lipoprotein, LDL Low Density Lipoprotein.and BMI indicated that rs34623097 was significantly
associated with triglycerides in Tongan subjects (Table 3).
A copy of the rs34623097-A allele, a risk allele for obesity
in Oceanic populations [8], increased serum triglyceride
levels by 70.1 mg/dL (0.791 mmol/L). No other significant
associations were detected. It is noted that the derived al-
lele, regardless of the allele frequency, was considered
when determining the direction of association in Table 3.
In this study, besides nine tag SNPs (rs17778257,
rs34623097, rs2895795, rs2053044, rs11959427, rs1042711,
rs1042713, rs1042714, and rs1042720) of ADRB2, the
rs1042719 SNP was further evaluated becausers 1042720,
being in LD with rs1042719 in the Oceanic populations
[8], showed a small P-value for triglyceride (P-value =
0.059; Table 3); however, the rs1042719 SNP was also not
significantly associated with the level of triglycerides
(P-value = 0.057).
To assess the possibility that the association of
rs34623097 with triglycerides is caused by nearby SNPs
being in LD with rs34623097, an additional multiple
regression analysis was further performed for 7 SNPs
imputed by the MACH software [9] by using the geno-
type data of HapMap East Asian populations (JPT +
CHB) as the reference panel. No SNPs other than
rs34623097 showed a significant association with tri-
glycerides (Figure 2).
Discussion
The present results indicate that rs34623097-A is associ-
ated with increased serum triglyceride levels. Our previous
luciferase reporter assay demonstrated that rs34623097-A
reduces the transcriptional activity of ADRB2 as compared
with rs34623097-G, and an electrophoretic mobility shift
assay suggested that rs34623097 modulates the binding af-
finity with nuclear factors [8]. Taken together, these results
indicate that the reduced expression of ADRB2 caused by
rs34623097-A on adipocytes might contribute, in part, to
increased serum triglyceride levels. One possible mechan-
ism is that the activation of β adrenergic receptors such as
ADRB2 expressed in adipocytes leads to the breakdown of
triglycerides stored in adipocytes and the release of free
fatty acids and glycerol [10-12]. Thus, the decreasedDependent variable
rol (mg/dL) LDL cholesterol (mg/dL) Triglyceride (mg/dL)
P-value β SE P-value β SE P-value
0.96 0.77 0.29 8.6 x 10-3 0.88 0.76 0.25
8.9 x 10-4 5.9 7.6 0.44 −94 20 6.6 x 1-6
3.0 x 10-4 0.60 0.57 0.30 3.4 1.5 0.026
x, and BMI with each lipid trait; BMI Body Mass Index, HDL High Density
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Figure 1 LD structure of ADRB2 SNPs. A pairwise r2 value is
shown in each square. Darker shading indicates higher r2 values and
black shading indicates an r2 of 1.
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Figure 2 Regional association plot. The genotypes of SNPs
around the ADRB2 gene in Tongan subjects were imputed by the
MACH software by using the genotype data of HapMap JPT and
CHB samples as the reference panel. The association P-values for 10
genotyped and 7 imputed SNPs are plotted as diamonds and circles,
respectively. The r2 between the SNP and rs34623097 is colored as a
scale from low (blue) to high (red). In the genomic region, there is
no protein-coding gene other than ADRB2.
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sion of ADRB2 that would result in the accumulation of
triglycerides within adipocytes. If triglycerides accumulate
in adipocytes, the cellular uptake of the major component
of triglycerides (i.e., free fatty acids) by adipocytes would
be reduced. This mechanism would reduce the lipolysis of
circulating lipoprotein-triglycerides. Accordingly, the level
of serum triglycerides would be increased in individuals
with rs34623097-A.
To the best of our knowledge, this study is the first to
report that rs34623097 is a major ADRB2 polymorphism
that influences the serum triglyceride level, although theTable 3 Association of each ADRB2 polymorphism with lipid
SNP Derived allele Frequency Total cholesterol
(mg/dL)
β SE P-value
rs17778257 T 0.39 5.17 5.52 0.351
rs34623097 A 0.04 13.7 14.6 0.350
rs2895795 A 0.52 −8.09 5.42 0.138
rs2053044 A 0.09 10.0 9.82 0.312
rs11959427a T 0.95 −8.00 13.5 0.557
rs1042711 (Arg19Cys) T (Cys) 0.95 −7.97 13.5 0.557
rs1042713 (Gly16Arg)a A (Arg) 0.42 5.70 5.30 0.285
rs1042714 (Glu27Gln)a C (Gln) 0.96 −8.50 14.6 0.563
rs1042719 C 0.43 4.42 5.38 0.413
rs1042720 A 0.61 −2.47 5.48 0.652
A multiple regression analysis adjusted for age, sex, and BMI was performed to exa
Mass Index, HDL High Density Lipoprotein, LDL Low Density Lipoprotein.
a The genotypes of subjects whose genotypes had not been determined by a molepossibility that the lack of association of the other
ADRB2 polymorphisms with lipid profiles comes from
the small sample size (n = 128) should not be excluded.
Previous studies have revealed that the 27Glu allele
(rs1042714-G) of ADRB2 significantly increases the
serum triglyceride levels [1-6]. In the present study, 27Glu
also showed the same tendency (i.e., the β coefficient of
27Gln, an alternative allele at Glu27Gln, was a negativetraits
HDL cholesterol
(mg/dL)
LDL cholesterol
(mg/dL)
Triglyceride
(mg/dL)
β SE P-value β SE P-value β SE P-value
0.110 1.06 0.918 4.34 4.83 0.371 8.20 12.8 0.523
−2.88 2.78 0.302 3.60 12.8 0.779 70.1 33.3 0.037
−0.0671 1.04 0.949 −6.18 4.75 0.196 −19.1 12.5 0.130
−0.128 1.88 0.946 6.35 8.61 0.462 36.3 22.6 0.111
1.70 2.60 0.503 −3.50 11.9 0.768 −36.1 31.2 0.250
1.74 2.58 0.503 −3.51 11.9 0.768 −36.1 31.2 0.250
0.400 1.00 0.720 4.50 4.70 0.344 13.9 12.5 0.267
2.10 2.80 0.443 −5.20 12.8 0.683 −37.9 33.7 0.263
−0.102 1.03 0.921 2.30 4.72 0.627 23.7 12.3 0.057
0.616 1.04 0.556 0.05 4.80 0.992 −23.8 12.5 0.059
mine the association of each polymorphism with each lipid trait; BMI Body
cular biology-based technique were imputed by using the MACH software.
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which is significantly associated with increased triglycer-
ides, is in positive LD with 27Glu in the Tongan subjects
(D’ = 1 and r2 = 0.62). The rs34623097-A allele is observed
mainly in Asians and Pacific Islanders and is in LD with
27Glu [8]. However, rs34623097-A had never previously
been examined in the association studies on lipid traits in-
cluding triglycerides. The significant association of 27Glu
found in previous studies may merely reflect the LD with
rs34623097-A. Further studies are required to clarify this
issue in various ethnic groups.
Subjects and methods
Subjects
A total of 128 healthy adult subjects (18 years old or
older) were recruited from Nuku’alofa, Tonga. Patients
with diabetes and subjects who had any treatment known
to interfere with metabolic syndrome-related parameters
were excluded. A blood sample was collected from each
subject after obtaining a written consent to participate in
the study. This study was approved by the National Health
Ethics & Research Committee of Tonga and the Research
Ethics Committee of the Faculty of Medicine, University
of Tsukuba.
Anthropometric measurements
Anthropomorphic phenotypes were directly measured in
field settings. Measurements were taken of subjects dressed
in light clothing. Body height was measured to the nearest
1 mm by using a field anthropometer (GPM, Zurich,
Switzerland), and weight was recorded to the nearest
0.1 kg by using a portable digital scale (Tanita model BC-
518, Tokyo, Japan). BMI was calculated by dividing the
weight in kg by the height in meters squared.
Methods
Blood samples were obtained on the morning following
a 12-hour fast. Serum lipids including total cholesterol,
HDL cholesterol, LDL cholesterol, and triglycerides were
measured at SRL Inc. (Tokyo, Japan) by using standard la-
boratory protocols.
Genotyping
Genomic DNA was extracted from peripheral blood by
using a QIAamp Blood Kit (Qiagen, Hilden, Germany).
Nine tag SNPs (rs17778257, rs34623097, rs2895795,
rs2053044, rs11959427, rs1042711, rs1042713, rs1042714,
and rs1042720) of ADRB2, which were in LD (r2 > 0.8)
with the other ADRB2 SNPs in the Oceanic populations,
were genotyped in our previous study [8]. The rs1042719
SNP was genotyped by using a TaqMan SNP genotyping
assay in the present study because rs1042720, being in LD
with rs1042719, showed not a significant but a small P-value in the association analyses of triglycerides in a
Tongan population.
Statistical analysis
Associations of age, sex, and BMI with total-cholesterol,
HDL-cholesterol, LDL-cholesterol or triglyceride levels
were assessed by a multiple regression analysis. The ge-
notypes of rs11959427, rs1042713, and rs1042714 were
not determined by a molecular biology-based technique
for some subjects; instead, their genotypes were imputed
by the MACH software [9]. Deviation of genotype fre-
quencies from Hardy-Weinberg equilibrium was exam-
ined by chi-square test. Pairwise linkage disequilibrium
(LD) parameters, D’ and r2, were estimated by using
Haploview software [13]. The association of each poly-
morphism with total cholesterol, HDL cholesterol, LDL
cholesterol or triglyceride levels was assessed by a multiple
regression analysis adjusted for age, sex, and BMI. In the
regression analysis, the number of copies of a derived al-
lele at each SNP was used as an independent variable (i.e.,
homozygotes of an ancestral allele, homozygotes of a de-
rived allele, and heterozygotes were coded as 0, 2, and 1,
respectively). The genotypes of SNPs with minor allele fre-
quency (MAF) of ≥ 0.05 spanning a 200 kb genomic re-
gion containing the entire ADRB2 gene were retrieved
from the HapMap JPT (Japanese in Tokyo, Japan) and
CHB (Han Chinese in Beijing, China) populations [14,15].
Furthermore, genomic DNA samples from 43 JPT and 45
CHB subjects were obtained from the Coriell Cell Reposi-
tory and subjected to rs34623097 genotyping [8]. By using
the genotype data of JPT and CHB subjects as a reference,
the genotypes of Tongan subjects were imputed by the
MACH software [9]. The imputed genotypes of SNPs
showing an Rsq value (a measure which estimates the
squared correlation between imputed and true genotypes)
of more than 0.5 were used for the association test. Ac-
cordingly, seven imputed SNPs were further subjected to
single-point association analysis. P-values less than 0.05
were regarded as statistically significant.
Conclusions
In a Tongan population, the rs34623097-A allele at a
SNP located in the upstream region of ADRB2 is signifi-
cantly associated with increased serum triglyceride levels
independent of BMI.
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